Sat Kartar Life Fair Value
Fair Value Analysis Export
P/B Based Valuation
Asset-Based Valuation
SATKARTAR Fair Value Analysis — Data Sources & Coverage
Sat Kartar Life financial data sources, valuation methods applied and sector benchmarks used.
Available Data Sources: Financial statements, dividend history, balance sheet data , sector comparisons.
SATKARTAR vs Healthcare Sector Peers — P/E, P/B & Market Cap
Sat Kartar Life P/E ratio, P/B ratio and market capitalisation vs Healthcare sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Jeena Sikho Lifecare | JSLL | 32.14 | 15.26 | ₹6,960 |
| SMS Lifesciences | SMSLIFE | 22.27 | 1.82 | ₹354 |
| Emcure Pharmaceuticals | EMCURE | 38.74 | 7.37 | ₹35,696 |
| Sai Life Sciences | SAILIFE | 78.41 | 11.02 | ₹26,771 |
| Aurobindo Pharma | AUROPHARMA | 25.44 | 2.35 | ₹89,736 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.